Cite
HARVARD Citation
Cocito, D. et al. (n.d.). Feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience. Clinical neurophysiology. 130 (1), pp. e12-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cocito, D. et al. (n.d.). Feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience. Clinical neurophysiology. 130 (1), pp. e12-. [Online].